Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

This publication has 40 references indexed in Scilit:

• Eight-year follow-up study of brain atrophy in patients with MS
  Neurology, 2002
• Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance
  Brain, 2002
• A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis
  New England Journal of Medicine, 2002
• Optimizing the association between disability and biological markers in MS
  Neurology, 2001
• A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis
  Journal of Neurology, Neurosurgery & Psychiatry, 2001
• Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a
  Multiple Sclerosis Journal, 2000
• Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
  New England Journal of Medicine, 2000
• Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis
  Current Opinion in Neurology, 1999
• The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
  Brain, 1998
• Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis
  Neurology, 1994